Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.
R W Davies, … , F N Hutchison, G A Kaysen
R W Davies, … , F N Hutchison, G A Kaysen
Published August 1, 1990
Citation Information: J Clin Invest. 1990;86(2):600-605. https://doi.org/10.1172/JCI114750.
View: Text | PDF
Research Article

Proteinuria, not altered albumin metabolism, affects hyperlipidemia in the nephrotic rat.

  • Text
  • PDF
Abstract

It has been established previously that nephrotic hyperlipidemia is characterized by both an increase in lipid synthesis and a defect in removal of lipoproteins. The relationship between these defects and altered albumin metabolism is uncertain. One hypothesis is that hepatic lipogenesis increases in parallel with albumin synthesis. To test this hypothesis, albumin synthesis was increased in nephrotic rats fed an 8.5% protein diet (LPN) by increasing dietary protein to 40% (HPN). Proteinuria was modulated in half of the rats fed 40% protein by enalapril (HPE). Albumin synthesis was the same in both HPN and HPE, but proteinuria was reduced in HPE compared to HPN, and so were serum cholesterol and triglycerides (TG). To examine the effect of serum albumin on lipid clearance in the absence of proteinuria, plasma clearance of chylomicrons (CM) and VLDL was measured in Nagase analbuminemic rats (NAR) and found to be no different than in normal SD rats. When proteinuria was induced in NAR and in SD rats, a severe and identical defect in both CM and VLDL clearance was acquired in both groups and blood lipid levels were increased to a similar degree in both groups. Neither hyperlipidemia nor defective removal of lipoproteins from the circulation are linked to albumin synthesis or serum albumin concentration but result, at least in part, from proteinuria. Postheparin lipoprotein lipase (LPL) activity was reduced slightly in nephrotic animals compared to nonnephrotic controls, but the most striking finding was a highly significant decrease in postheraprin LPL activity in normal NAR compared to SD rats (P less than 0.001), suggesting that reduced LPL activity is not responsible for reduced clearance of CM and VLDL in nephrotic rats.

Authors

R W Davies, I Staprans, F N Hutchison, G A Kaysen

×

Total citations by year

Year: 2021 2020 2019 2017 2016 2015 2013 2012 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 Total
Citations: 1 1 2 1 2 1 3 2 1 1 1 1 1 3 3 1 3 5 2 4 3 8 3 5 6 7 3 4 78
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (78)

Title and authors Publication Year
Albumin is an interface between blood plasma and cell membrane, and not just a sponge.
van de Wouw J, Joles JA
Clinical Kidney Journal 2021
Kidney-derived PCSK9—a new driver of hyperlipidemia in nephrotic syndrome?
F Artunc
Kidney International 2020
Kidney Lipidomics by Mass Spectrometry Imaging: A Focus on the Glomerulus
I Abbas, M Noun, D Touboul, D Sahali, A Brunelle, M Ollero
International journal of molecular sciences 2019
Endocrine Disorders in Kidney Disease: Diagnosis and Treatment
CM Rhee, K Kalantar-Zadeh, GA Brent
2019
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment
S Agrawal, JJ Zaritsky, A Fornoni, WE Smoyer
Nature Reviews Nephrology 2017
Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences
ND Vaziri
Kidney International 2016
Treatment of Hyperlipidemia Changes With Level of Kidney Function—Rationale
S Ananthakrishnan, GA Kaysen
Advances in Chronic Kidney Disease 2016
Dyslipidemias: Pathophysiology, Evaluation and Management
A Garg
2015
Nutritional Management of Renal Disease
A Molfino, BR Don, GA Kaysen
Nutritional Management of Renal Disease 2013
Seldin and Giebisch's The Kidney
CJ Cooper, LD Dworkin, WL Henrich
Seldin and Giebisch's The Kidney 2013
Hepatic fatty acid and cholesterol metabolism in nephrotic syndrome
S Han, ND Vaziri, P Gollapudi, V Kwok, H Moradi
American journal of translational research 2013
Brenner and Rector's The Kidney
C Brugnara, KU Eckardt
Brenner and Rector's The Kidney 2012
Proteinuria decreases tissue lipoprotein receptor levels resulting in altered lipoprotein structure and increasing lipid levels
L Wang, GC Shearer, MS Budamagunta, JC Voss, A Molfino, GA Kaysen
Kidney International 2012
Lack of plasma albumin impairs intravascular lipolysis and explains the associated free fatty acids deficiency and hypertriglyceridemia
TR Figueira, AE Vercesi, HC Oliveira
Lipids in Health and Disease 2010
Omega-3 fatty acids improve postprandial lipaemia in patients with nephrotic range proteinuria
S Bell, J Cooney, CJ Packard, M Caslake, CJ Deighan
Atherosclerosis 2009
Nutrition in Kidney Disease
LD Byham-Gray, GM Chertow, JD Burrowes
2008
Longitudinal examination of lipid profiles in pediatric systemic lupus erythematosus
T Sarkissian, J Beyene, B Feldman, B McCrindle, ED Silverman
Arthritis & Rheumatism 2007
Endothelial bound lipoprotein lipase (LpL) depletion in hypoalbuminemia results from decreased endothelial binding, not decreased secretion
GC Shearer, GA Kaysen
Kidney International 2006
Regulation of Epithelial Sodium Channel in Puromycin Aminonucleoside-Induced Unilateral Experimental Nephrotic Syndrome in Normal and Analbuminemic Nagase Rats
Z Yu, M Schumacher, BM Frey, FJ Frey, B Vogt
Nephron Physiology 2005
Statins in nephrotic syndrome: A new weapon against tissue injury
M Buemi, L Nostro, E Crascì, A Barillà, V Cosentini, C Aloisi, T Sofi, S Campo, N Frisina
Medicinal Research Reviews 2005
Effects of gender on hepatic HMG-CoA reductase, cholesterol 7α-hydroxylase, and LDL receptor in hereditary analbuminemia
Y Shin, ND Vaziri, N Willekes, CH Kim, JA Joles
American journal of physiology. Endocrinology and metabolism 2005
Up-regulation of hepatic Acyl CoA: Diacylglycerol acyltransferase-1 (DGAT-1) expression in nephrotic syndrome
ND Vaziri, CH Kim, D Phan, S Kim, K Liang
Kidney International 2004
Nephrotic livers secrete normal VLDL that acquire structural and functional defects following interaction with HDL
GC Shearer, WG Couser, GA Kaysen
Kidney International 2004
Effect of Lovastatin on lipid peroxidation and total antioxidant concentrations in hemodialysis patients
H Argani, A Ghorbani, N Rashtchizade, M Rahbaninobar
Lipids in Health and Disease 2004
Molecular mechanisms of lipid disorders in nephrotic syndrome
ND Vaziri
Kidney International 2003
Up-regulation of acyl-coenzyme A:cholesterol acyltransferase (ACAT) in nephrotic syndrome
ND Vaziri, K Liang
Kidney International 2002
Comorbidity and Cardiovascular Risk Factors in Patients With Chronic Kidney Disease
J Paparello, A Kshirsagar, D Batlle
Seminars in Nephrology 2002
Improving Prognosis for Kidney Disorders
MM Avram
2002
Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome1
GC Shearer, FT Stevenson, DN Atkinson, H Jones, I Staprans, GA Kaysen
Kidney International 2001
Endothelial chylomicron binding is altered by interaction with high-density lipoprotein in Heymann's nephritis
GC Shearer, WG Couser, GA Kaysen
American Journal of Kidney Diseases 2001
Proteinuria and plasma compositional changes contribute to defective lipoprotein catabolism in the nephrotic syndrome by separate mechanisms
GC Shearer, GA Kaysen
American Journal of Kidney Diseases 2001
Plasma protein synthesis in patients with low-grade nephrotic proteinuria
M Zanetti, R Barazzoni, G Garibotto, G Davanzo, C Gabelli, E Kiwanuka, A Piccoli, M Tosolini, P Tessari
American journal of physiology. Endocrinology and metabolism 2001
Acquired lecithin-cholesterol acyltransferase deficiency in nephrotic syndrome
ND Vaziri, K Liang, JS Parks
American journal of physiology. Renal physiology 2001
Estrogen effects on triglyceride metabolism in analbuminemic rats
GC Shearer, JA Joles, H Jones, RL Walzem, GA Kaysen
Kidney International 2000
Early Mechanisms of Renal Injury in Hypercholesterolemic or Hypertriglyceridemic Rats
JA Joles, U Kunter, U Janssen, W Kriz, TJ Rabelink, HA Koomans, J Floege
Journal of the American Society of Nephrology : JASN 2000
New insights into lipid metabolism in the nephrotic syndrome
GA Kaysen, MG de der Velden
Kidney International 1999
Lipid-lowering therapy in membranous nephropathy
M Haas, D Kerjaschki, G Mayer
Kidney International 1999
Lipopheresis in the nephrotic syndrome
C Brunton, Z Varghese, JF Moorhead
Kidney International 1999
Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure
HJ Milionis, MS Elisaf, A Tselepis, E Bairaktari, SA Karabina, KC Siamopoulos
American Journal of Kidney Diseases 1999
The full induction of human apoprotein A-I gene expression by the experimental nephrotic syndrome in transgenic mice depends on cis-acting elements in the proximal 256 base-pair promoter region and the trans-acting factor early growth response factor 1
M Zaiou, N Azrolan, T Hayek, H Wang, L Wu, M Haghpassand, B Cizman, MP Madaio, J Milbrandt, JB Marsh, JL Breslow, EA Fisher
Journal of Clinical Investigation 1998
Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis
MG de der Velden, GA Kaysen, HA Barrett, F Stellaard, MM Gadellaa, HA Voorbij, DJ Reijngoud, TJ Rabelink
Kidney International 1998
The Nephrotic Syndrome
SR Orth, E Ritz
New England Journal of Medicine 1998
Combination of vasopressin and angiotensin inhibition in experimental focal glomerulosclerosis
I KURIHARA, T SAITO, K OBARA, M HIRAI, J SOMA, H SATO, K ABE
Nephrology 1997
Effect of increasing serum albumin on serum lipoprotein(a) concentration in patients receiving CAPD
WS Yang, WK Min, JS Park, SB Kim
American Journal of Kidney Diseases 1997
Gene expression of lipoprotein lipase in experimental nephrosis
K Liang, ND Vaziri
Journal of Laboratory and Clinical Medicine 1997
Hypoalbuminemia causes high blood viscosity by increasing red cell lysophosphatidylcholine
JA Joles, N Willekes-Koolschijn, HA Koomans
Kidney International 1997
Suki and Massry’s THERAPY OF RENAL DISEASES AND RELATED DISORDERS
WN Suki, SG Massry
1997
Lipoprotein Kinetics in Patients With Analbuminemia: Evidence for the Role of Serum Albumin in Controlling Lipoprotein Metabolism
C Maugeais, S Braschi, K Ouguerram, P Maugeais, P Mahot, B Jacotot, D Darmaun, T Magot, M Krempf
Arteriosclerosis, thrombosis, and vascular biology 1997
Role of Lipoprotein-Bound NEFAs in Enhancing the Specific Activity of Plasma CETP in the Nephrotic Syndrome
S Braschi, D Masson, G Rostoker, E Florentin, A Athias, C Martin, B Jacotot, P Gambert, C Lallemant, L Lagrost
Arteriosclerosis, thrombosis, and vascular biology 1997
Plasma protein abnormalities in nephrotic syndrome: effect on plasma colloid osmotic pressure and viscosity
J Joven, X Clivillé, J Camps, E Espinel, J Simó, E Vilella, A Oliver
Clinical chemistry 1997
The influence of hypoalbuminemia in the generation of nephrotic hyperlipidemia
J Joven, E Espinel, JM Simó, E Vilella, J Camps, A Oliver
Atherosclerosis 1996
Will angiotensin II receptor antagonists be renoprotective in humans?
I Ichikawa
Kidney International 1996
The serum lathosterol to cholesterol ratio, an index of cholesterol synthesis, is not elevated in patients with glomerular proteinuria and is not associated with improvement of hyperlipidemia in response to antiproteinuric treatment
RP Dullaart, RT Gansevoort, WJ Sluiter, D Zeeuw, PE de Jong
Metabolism 1996
Plasma triglyceride levels are higher in nephrotic than in analbuminemic rats despite a similar increase in hepatic triglyceride secretion
JA Joles, C Bijleveld, A Tol, MJ Geelen, HA Koomans
Kidney International 1995
Metabolism of low density lipoproteins in nephrotic dyslipidemia: Comparison of hypercholesterolemia alone and combined hyperlipidemia
GL Vega, RD Toto, SM Grundy
Kidney International 1995
Effect of oncotic pressure on apolipoprotein A-I metabolism in the rat
GA Kaysen, E Hoye, H Jones, A Tol, JA Joles
American Journal of Kidney Diseases 1995
Ovariectomy decreases plasma triglyceride levels in analbuminaemic rats by lowering hepatic triglyceride secretion
JA Joles, C Bijleveld, A Tol, MJ Geelen, HA Koomans
Atherosclerosis 1995
Selected Aspects of ACE Inhibitor Therapy for Patients with Renal Disease: Impact on Proteinuria, Lipids and Potassium
T Keilani, W Schlueter, D Batlle
The Journal of Clinical Pharmacology 1995
Albumin and transferrin synthesis are increased in H4 cells by serum from analbuminemic or nephrotic rats
X Sun, GA Kaysen
Kidney International 1994
Nagase analbuminemic rats have faster plasma triacylglycerol and VLDL synthesis rates
S Catanozzi, JC Rocha, ER Nakandakare, HC Oliveira, EC Quintão
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1994
Extrarenal Complications of the Nephrotic Syndrome
RC Harris, N Ismail
American Journal of Kidney Diseases 1994
Lipid Abnormalities in the Nephrotic Syndrome: Causes, Consequences, and Treatment
DC Wheeler, DB Bernard
American Journal of Kidney Diseases 1994
Synergistic Effects of Fish Oil Diet and Dimethylthiourea in Acute Adriamycin Nephrosis
LS Milner, S Wei, P Kazakoff, L Watkins, MT Houser
The American Journal of the Medical Sciences 1994
Reduction of hyperlipidemia and proteinuria without growth retardation in nephritic rats by amino acids-fortified low casein diets
K Fujisawa, K Yagasaki, R Funabiki
The Journal of Nutritional Biochemistry 1994
Hyperlipidemia in childhood nephrotic syndrome
MA Thabet, JR Salcedo, JC Chan
Pediatric Nephrology 1993
Lipid synthesis and apolipoprotein gene expression in hepatocytes in primary culture from (puromycin-induced) nephrotic rats
SE Boustani, A Ribeiro, B Janvier, C Loriette, R Bensman, P Druet, J Chambaz, M Mangeney
European Journal of Clinical Investigation 1993
Lipoprotein(a) in nephrotic syndrome
P Stenvinkel, L Berglund, O Heimbürger, E Pettersson, A Alvestrand
Kidney International 1993
Receptor-mediated uptake of IDL and LDL from nephrotic patients by glomerular epithelial cells
A Krämer, M Nauck, H Pavenstädt, S Schwedler, H Wieland, P Schollmeyer, C Wanner
Kidney International 1993
Electrophoretic Analysis of Serum and Urinary Proteins in Rats with Aminonucleoside-Induced Nephrotic Syndrome
J Pedraza-Chaverri, P Calderón, C Cruz, JC Peña
Renal Failure 1993
Metabolic effects of converting enzyme inhibitors: Focus on the reduction of cholesterol and lipoprotein(a) by fosinopril
W Schlueter, T Keilani, DC Batlle
The American Journal of Cardiology 1993
Defective Lipolysis Persists in Hearts of Rats With Heymann Nephritis in the Absence of Nephrotic Plasma
GA Kaysen, XM Pan, WG Couser, I Staprans
American Journal of Kidney Diseases 1993
Activity of Serum Enzymes in Puromycin Aminonucleoside-Induced Nephrotic Syndrome
J Pedraza-Chaverri, C Cruz, E Tapia, JC PeÑA
Renal Failure 1992
Plasma lipoproteins and cholesterol metabolism in Yoshida rats: An animal model of spontaneous hyperlipemia
S Fantappiè, AL Catapano, M Cancellieri, L Fasoli, ED Fabiani, M Bertolini, E Bosisio
Life Sciences 1992
Nutritional Management of Nephrotic Syndrome
GA Kaysen
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 1992
Lipid abnormalities in renal disease
G Appel
Kidney International 1991
Influence of age-related nephropathy on plasma lipoproteins of the aging rat
S Calandra, P Tarugi
Aging clinical and experimental research 1991
Dyslipoproteinemia in an inbred rat strain with spontaneous chronic progressive nephrotic syndrome
P Tarugi, S Nicolini, L Albertazzi, S Calandra, P Salvati, C Ferti, C Patrono
Journal of lipid research 1991
Hyperlipoproteinemia in Nagase analbuminemic rats: effects of pravastatin on plasma (apo)lipoproteins and lecithin:cholesterol acyltransferase activity
AV Tol, EH Jansen, HA Koomans, JA Joles
Journal of lipid research 1991

← Previous 1 2 3 4 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts